Using a Program to Lower Stress for Caregivers of Patients With Cancer Who Have Received Stem Cell Transplants
Mark L. Laudenslager(University of Colorado Anschutz Medical Campus), Peter A. McSweeney(Mesoblast (United States)), Kristin Kilbourn(University of Colorado Denver), Benjamin W. Brewer(University of Colorado Anschutz Medical Campus), Jon Gutman(University of Colorado Anschutz Medical Campus), Teresa L. Simoneau(University of Colorado Anschutz Medical Campus), Susan K. Mikulich‐Gilbertson(University of Colorado Anschutz Medical Campus)
Cited by 1
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k